Keurig Dr Pepper (NASDAQ:KDP) Rating Lowered to Underperform at BNP Paribas Exane

Key Points

• Keurig Dr Pepper has been downgraded by BNP Paribas Exane from a "neutral" to an "underperform" rating, reflecting a negative outlook for the stock.
• The company has seen changes in ratings from several analysts, with HSBC also downgrading its rating and adjusting its price target down from $42.00 to $30.00.
• Keurig Dr Pepper's stock opened at $27.11, with a 12-month trading range between $26.58 and $38.28, suggesting recent volatility and investor caution.

Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) was downgraded by investment analysts at BNP Paribas Exane from a "neutral" rating to an "underperform" rating in a research note issued on Monday, Marketbeat.com reports.

Several other analysts have also recently commented on the stock. Hsbc Global Res cut shares of Keurig Dr Pepper from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, August 26th. BNP Paribas cut shares of Keurig Dr Pepper from a "neutral" rating to an "underperform" rating in a research note on Monday. UBS Group reduced their price objective on shares of Keurig Dr Pepper from $40.00 to $35.00 and set a "buy" rating on the stock in a research note on Wednesday, August 27th. Jefferies Financial Group set a $41.00 price objective on shares of Keurig Dr Pepper in a research note on Monday, August 25th. Finally, Citigroup reduced their price objective on shares of Keurig Dr Pepper from $41.00 to $37.00 and set a "buy" rating on the stock in a research note on Tuesday, September 16th. Eleven analysts have rated the stock with a Buy rating, three have issued a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, Keurig Dr Pepper currently has an average rating of "Moderate Buy" and a consensus price target of $37.77.

Keurig Dr Pepper Stock Performance

NASDAQ KDP opened at $26.50 on Monday. The firm has a market cap of $36.00 billion, a price-to-earnings ratio of 23.66, a PEG ratio of 1.42 and a beta of 0.47. The company has a 50 day moving average of $31.41 and a 200-day moving average of $32.94. The company has a current ratio of 0.64, a quick ratio of 0.40 and a debt-to-equity ratio of 0.56. Keurig Dr Pepper has a 1-year low of $25.92 and a 1-year high of $38.28.

Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last posted its quarterly earnings data on Thursday, July 24th. The company reported $0.49 earnings per share for the quarter, hitting the consensus estimate of $0.49. The company had revenue of $4.16 billion during the quarter, compared to analyst estimates of $4.14 billion. Keurig Dr Pepper had a net margin of 9.75% and a return on equity of 11.05%. The company's revenue was up 6.1% on a year-over-year basis. During the same quarter last year, the business posted $0.45 earnings per share. On average, equities analysts forecast that Keurig Dr Pepper will post 1.92 earnings per share for the current fiscal year.

Insider Buying and Selling at Keurig Dr Pepper

In related news, Director Robert James Gamgort sold 7,601 shares of the business's stock in a transaction on Wednesday, August 20th. The shares were sold at an average price of $35.91, for a total value of $272,951.91. Following the sale, the director directly owned 2,284,568 shares of the company's stock, valued at approximately $82,038,836.88. The trade was a 0.33% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Mary Beth Denooyer sold 12,000 shares of Keurig Dr Pepper stock in a transaction on Thursday, July 17th. The shares were sold at an average price of $33.66, for a total transaction of $403,920.00. Following the completion of the sale, the insider owned 82,511 shares in the company, valued at $2,777,320.26. The trade was a 12.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 447,601 shares of company stock worth $14,825,192 over the last ninety days. 1.00% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Keurig Dr Pepper

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Asset Dedication LLC grew its stake in Keurig Dr Pepper by 3.8% in the 2nd quarter. Asset Dedication LLC now owns 7,922 shares of the company's stock valued at $262,000 after buying an additional 288 shares during the last quarter. Croban grew its stake in Keurig Dr Pepper by 0.9% in the 2nd quarter. Croban now owns 31,849 shares of the company's stock valued at $1,053,000 after buying an additional 294 shares during the last quarter. Auxier Asset Management grew its stake in Keurig Dr Pepper by 0.4% in the 2nd quarter. Auxier Asset Management now owns 72,163 shares of the company's stock valued at $2,386,000 after buying an additional 318 shares during the last quarter. Private Trust Co. NA grew its position in shares of Keurig Dr Pepper by 26.4% during the 2nd quarter. Private Trust Co. NA now owns 1,624 shares of the company's stock worth $54,000 after purchasing an additional 339 shares in the last quarter. Finally, Commerce Bank grew its position in shares of Keurig Dr Pepper by 1.6% during the 1st quarter. Commerce Bank now owns 21,513 shares of the company's stock worth $736,000 after purchasing an additional 340 shares in the last quarter. 93.99% of the stock is currently owned by institutional investors and hedge funds.

About Keurig Dr Pepper

Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.